Symbol
| SOX5
| contributors: shn/pgu - updated : 20-03-2019
|
HGNC name
| SRY (sex determining region Y)-box 5
|
HGNC id
| 11201
|
corresponding disease(s)
|
LAMSHF
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
| amplification
|  
|  
|
coamplified with DADR and EKI1 in testicular seminoma | tumoral
|  
|  
| --over
|  
|
in breast cancer tissues compared with adjacent healthy tissues, and overexpression of SOX5 was associated with a reduced overall survival rate in patients with breast cancer | |
Variant & Polymorphism
|
| |
Candidate gene
| novel candidate gene for late-onset familial Alzheimer disease (LOAD with an important role in neuronal function |
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | reproductive | breast | |
candidate therapeutic target in breast cancer progression | cancer | digestive | liver | |
may be a potential therapeutic target for HCC metastasis |
| | |
| Sox6 single null mice are born with mild skeletal abnormalities | |
Sox5-Sox6 double null fetuses die with a severe, generalized chondrodysplasia |
|
silencing of the Drosophila ortholog of Sox5 leads to abnormal neuronal development and behavioral impairment |